Uzbekistan Cough Syrup Deaths
-
{
- All
- News
-
Indian Among 21 Sentenced In Uzbekistan Over Cough Syrup Deaths
- Monday February 26, 2024
- India News | Agence France-Presse
Uzbekistan on Monday handed out sentences to 21 people linked to the deaths of 68 children who consumed a contaminated cough syrup produced in India.
-
www.ndtv.com
-
Uzbekistan Syrup Deaths: Noida Firm's Licence Cancelled By Uttar Pradesh
- Wednesday March 22, 2023
- India News | Press Trust of India
The manufacturing licence of Noida-based pharmaceutical firm Marion Biotech was cancelled on Wednesday by Uttar Pradesh authorities, according to officials.
-
www.ndtv.com
-
Uzbekistan Syrup Deaths: Process Initiated To Cancel Noida Firm's Licence
- Sunday March 5, 2023
- India News | Press Trust of India
The process has been initiated for cancellation of the drug licence of pharmaceutical firm Marion Biotech, which is allegedly linked with the death of 18 children in Uzbekistan who consumed their cough syrup in December 2022, officials in Noida said.
-
www.ndtv.com
-
Indian Among 21 Sentenced In Uzbekistan Over Cough Syrup Deaths
- Monday February 26, 2024
- India News | Agence France-Presse
Uzbekistan on Monday handed out sentences to 21 people linked to the deaths of 68 children who consumed a contaminated cough syrup produced in India.
-
www.ndtv.com
-
Uzbekistan Syrup Deaths: Noida Firm's Licence Cancelled By Uttar Pradesh
- Wednesday March 22, 2023
- India News | Press Trust of India
The manufacturing licence of Noida-based pharmaceutical firm Marion Biotech was cancelled on Wednesday by Uttar Pradesh authorities, according to officials.
-
www.ndtv.com
-
Uzbekistan Syrup Deaths: Process Initiated To Cancel Noida Firm's Licence
- Sunday March 5, 2023
- India News | Press Trust of India
The process has been initiated for cancellation of the drug licence of pharmaceutical firm Marion Biotech, which is allegedly linked with the death of 18 children in Uzbekistan who consumed their cough syrup in December 2022, officials in Noida said.
-
www.ndtv.com